Brief: Tiziana Life Sciences Granted FDA Fast Track Designation
24/07/2024 13:04
July 24 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES GRANTED FDA FAST TRACK DESIGNATION
* TIZIANA LIFE SCIENCES LTD - FDA GRANTS FAST TRACK FOR
INTRANASAL
FORALUMAB
* TIZIANA LIFE SCIENCES: INTENDS TO TIMELY REQUEST A HEARING
BEFORE NASDAQ HEARINGS PANEL WHICH REQUEST WILL STAY ANY
DELISTING ACTION BY NASDAQ
Source text for Eikon: ID:nGNX4qj8d1
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study